Percutaneus Coronary Intervention
DeviceCovered Stent
NCT Number: NCT04630314
Covered stents have been mainly used for treatment of potentially life-threatening coronary artery perforation and coronary artery aneurysm. Prior studies suggest that the use of covered stents improves event-free survival, enabling a life-threatening situation to be managed without emergency surgery and with significantly reduced rates of mortality, cardiac tamponade, and major adverse cardiac events. Although the devices are used for a long time, very limited study has described procedural-related outcomes with this specific technology. We therefore want to report procedural, in-hospital and long term outcomes among patients treated with the covered stents.
Looking for future studies?
Notify MeObservational
Department of Invasive Cardiology, Medical University of Białystok, Bialystok, Poland
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Covered Stent
Time frame: 1 year
MACE
Time frame: 1 year
ST
Time frame: 1 year
CV Death
Time frame: 1 year
TLR
Time frame: 1 year
MI
Medical University of Silesia
Other
Procedural and 1-year Outcomes Following Large Vessel Coronary Artery Perforation Treated by Covered Stents Implantation: Multicentre CRACK Registry
Acronym: CRACK
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04849169
Coronary Artery Perforation
Atlanta, Georgia, United States
View Trial DetailsNCT03862352
Coronary Artery Perforation, Coronary Stent Occlusion
Glasgow, United Kingdom
View Trial Details